These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. [Determination of anti-double stranded DNA antibodies by the Crithidia Luciliae immunofluorescence method and its clinical significance]. Hu DW. Zhonghua Nei Ke Za Zhi; 1983 Jun; 22(6):336-8. PubMed ID: 6357662 [No Abstract] [Full Text] [Related]
48. An immunofluorescence assay for double-stranded DNA antibodies using the Crithidia luciliae kinetoplast as a double-stranded DNA substrate. Sontheimer RD, Gilliam JN. J Lab Clin Med; 1978 Apr; 91(4):550-8. PubMed ID: 347011 [Abstract] [Full Text] [Related]
49. Complement-fixing antibodies to dsDNA detected by the immunofluorescence technique on Crithidia luciliae. A critical appraisal. Esparza RH, Swaak T, Aarden L, Smeenk R. J Rheumatol; 1985 Dec; 12(6):1109-17. PubMed ID: 3912506 [Abstract] [Full Text] [Related]
50. Double stranded DNA antibody quantification by the FARR assay and indirect immunofluorescence test using Crithidia lucilae. Graafland HF, Wagner AL. Int J Nucl Med Biol; 1982 Dec; 9(2):114-7. PubMed ID: 7049985 [No Abstract] [Full Text] [Related]
51. Significant differences in the analytic concordance between anti-dsDNA IgG antibody assays for the diagnosis of systemic lupus erythematosus--implications for inter-laboratory testing. Chiaro TR, Davis KW, Wilson A, Suh-Lailam B, Tebo AE. Clin Chim Acta; 2011 May 12; 412(11-12):1076-80. PubMed ID: 21352819 [Abstract] [Full Text] [Related]
52. The significance of discrepant Farr and Crithidia luciliae tests. McGuigan L, Edmonds J, Wellings G, Jones M. J Rheumatol; 1984 Apr 12; 11(2):172-4. PubMed ID: 6610050 [Abstract] [Full Text] [Related]
53. Measurement of anti-DNA antibodies by ELISA: a comparative study with Crithidia and a Farr assay. Tipping PG, Buchanan RC, Riglar AG, Dimech WJ, Littlejohn GO, Holdsworth SR. Pathology; 1991 Jan 12; 23(1):21-4. PubMed ID: 2062564 [Abstract] [Full Text] [Related]
56. Clinical significance of ELISA positive and immunofluorescence negative anti-dsDNA antibody. Kim KH, Han JY, Kim JM, Lee SW, Chung WT. Clin Chim Acta; 2007 May 01; 380(1-2):182-5. PubMed ID: 17355877 [Abstract] [Full Text] [Related]
57. Complement fixing antibodies to DS-DNA in systemic lupus erythematosus: a study using the immunofluorescent Crithidia luciliae method. Beaulieu A, Quismorio FP, kitridou RC, Friou GJ. J Rheumatol; 1979 May 01; 6(4):389-96. PubMed ID: 392093 [Abstract] [Full Text] [Related]
58. Longitudinal study of patients with discrepant results in CLIFT and a solid-phase dsDNA antibody assay: does a gold standard dsDNA assay exist? Trujillo Aguilera A, Bernardo Serrano R, Navas A, Alcaide Molina J, Alvarez Romero P, Jurado Roger A. Lupus Sci Med; 2023 Oct 01; 10(2):. PubMed ID: 37903589 [Abstract] [Full Text] [Related]